乳腺与前列腺癌前病变至侵袭性癌转变的空间图谱
研究利用光片显微镜在多例完整肿瘤中识别癌前与侵袭区域间的移行交界,并开发整合容积重建与空间转录组学的多模态连续切片工作流,分析51例319个空间检测,揭示乳腺和前列腺癌侵袭转变的基因表达特征与结构新见解。
要点
- 乳腺侵袭转变与MGP和PLAT缺失相关并在功能实验促进肿瘤发生
- 前列腺侵袭进展中GDF15、ALDH1A3、ANPEP和FASN上调,敲低抑制PC-3增殖迁移
- 非三阴性乳腺癌转变区富集SPP1+和MS4A6A+肿瘤相关巨噬细胞提示免疫参与
核心结论
- 定义侵袭转变精确空间位置的方法可直接探究转变驱动因素,为两种最常见癌症提供新治疗靶点。
研究设计与样本
- 对完整肿瘤行光片显微镜识别癌前与侵袭区域间移行交界。
- 开发整合容积重建与空间转录组学的多模态连续切片工作流。
- 分析51例319个空间检测。
主要发现
- 分析揭示定义癌前向侵袭性疾病转变的基因表达特征与结构新见解。
- 乳腺癌中MGP和PLAT缺失与侵袭转变相关并在功能实验促进肿瘤发生。
- 前列腺癌中GDF15、ALDH1A3、ANPEP和FASN沿侵袭进展上调,敲低PC-3细胞抑制增殖和迁移。
- 非三阴性乳腺癌转变区富集SPP1+和MS4A6A+肿瘤相关巨噬细胞,提示免疫参与侵袭性驱动。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Breast and prostate cancers are both hormone-driven adenocarcinomas that undergo analogous invasion programs. Using lightsheet microscopy on intact tumors, we identified transitional junctions between precancerous and invasive regions. We then developed a multimodal serial-section workflow integrating volumetric reconstruction with spatial transcriptomics. Analysis of 319 spatial assays from 51 cases revealed gene expression features and novel structural insights defining the shift from precancer to invasive disease. In breast cancer, loss of MGP and PLAT was associated with invasive transition and promoted tumorigenesis in functional assays. In prostate cancer, GDF15, ALDH1A3, ANPEP, and FASN were upregulated along invasive progression, and their knockdown in PC-3 cells suppressed proliferation and migration. Enrichment of tumor-associated macrophages (SPP1+ and MS4A6A+) along non-triple-negative breast cancer breast cancer transitions highlights immune involvement as a potential driver of invasiveness. SIGNIFICANCE: Our method of defining precise spatial locations of invasive transition allows for the direct interrogation of transition drivers, presenting new therapeutic targets for the two most prevalent cancers and providing a framework for studying spatially defined mechanisms of tumor progression. See related commentary by Jing and Li, p. 1720.
引用
- Storrs E, Mo CK, Chou WH, et al. Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate. Cancer Discov. 2026. PMID: 41997105. doi:10.1158/2159-8290.CD-26-0012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。